Patents Assigned to Acacia Pharma Ltd
  • Publication number: 20230263770
    Abstract: Amisulpride is useful in the therapy (particularly the prevention of) post-operative nausea and/or vomiting (PONV) in a patient, particularly wherein the patient has a high (?30) BMI and/or the patient is a bariatric surgery patient.
    Type: Application
    Filed: July 6, 2021
    Publication date: August 24, 2023
    Applicant: ACACIA PHARMA LTD
    Inventors: Julian Clive GILBERT, Gabriel FOX, Robert William GRISTWOOD
  • Patent number: 11357753
    Abstract: Amisulpride is useful in the treatment of postoperative nausea and/or vomiting in a patient, wherein the patient has already been administered a prophylaxis drug for postoperative nausea and/or vomiting, and wherein the dose of amisulpride is 7.5 to 15 mg.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: June 14, 2022
    Assignee: Acacia Pharma Ltd
    Inventors: Julian Clive Gilbert, Robert William Gristwood, Gabriel Fox